Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
It can also be more cost-effective
Tirzepatide targets two hormone pathways, while Retatrutide is studied for triple-pathway signaling
Peptides are to be used for research purposes and are not approved for human consumption
In the SURMOUNT-1 trial, participants on 10mg achieved an average weight reduction of 21.4%, losing roughly 49 pounds over 72 weeks
Wonderful product I am very satisfied with the results of using this drug
US$ 25.60
US$ 29.88
US$ 25.37
US$ 25.22
